ENA-001
- Generic Name
- ENA-001
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H22N6O
- CAS Number
- 1380341-99-0
- Unique Ingredient Identifier
- 4RZ4OGT40Z
- Associated Conditions
- -
- Associated Therapies
- -
Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001
Enalare Therapeutics received FDA clearance for a phase I study of ENA-001, a novel respiratory stimulant for treating respiratory depression from drug overdose, using both IM and IV formulations. The study is funded by BARDA and supported by NIDA.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath